Literature DB >> 23380629

Expression of toll-like receptors in chronic otitis media and cholesteatoma.

Haruka Hirai1, Shin Kariya, Mitsuhiro Okano, Kunihiro Fukushima, Yuko Kataoka, Yukihide Maeda, Kazunori Nishizaki.   

Abstract

OBJECTIVE: Otitis media is one of the most common infectious diseases, especially in young children. Multiple factors affect the onset or development of otitis media. Human toll-like receptors recognize associated patterns and play a critical role in innate immune mechanisms. Toll-like receptors are considered to be important factors for clearance of infection and resolution of inflammation in otitis media. The purpose of this study was to evaluate the histological expression of toll-like receptor 2, which recognizes many kinds of pathogen-associated molecular patterns, and toll-like receptor 4, which recognizes lipopolysaccharide on Gram-negative bacteria, in tissue samples from patients with chronic otitis media and middle ear cholesteatoma.
METHODS: Human middle ear tissue samples from 12 patients with chronic otitis media (n=7) and acquired middle ear cholesteatoma (n=5) were examined. Normal control middle ear samples without any inflammation were also included (n=7). The expressions of toll-like receptors 2 and 4 in middle ear tissues were examined immunohistochemically.
RESULTS: Only one normal control middle ear sample showed weak expression of toll-like receptor 2, and toll-like receptor 4 was not observed in all control samples. On the other hand, both toll-like receptors 2 and 4 were markedly expressed in chronic otitis media and cholesteatoma. There was a significant difference between chronic otitis media and normal controls in the expressions of both toll-like receptors. Significant up-regulation of toll-like receptors 2 and 4 was observed in cholesteatoma as compared with control samples.
CONCLUSIONS: Toll-like receptors 2 and 4 were strongly expressed in chronic otitis media and middle ear cholesteatoma. These findings suggest that toll-like receptors may play a principal role in human chronic otitis media and cholesteatoma.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380629     DOI: 10.1016/j.ijporl.2013.01.010

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Stem cells in middle ear cholesteatoma contribute to its pathogenesis.

Authors:  Julia Nagel; Saskia Wöllner; Matthias Schürmann; Viktoria Brotzmann; Janine Müller; Johannes Fw Greiner; Peter Goon; Barbara Kaltschmidt; Christian Kaltschmidt; Holger Sudhoff
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

3.  Immunomodulation as a Protective Strategy in Chronic Otitis Media.

Authors:  Anke Leichtle; Arwa Kurabi; David Leffers; Markus Därr; Clara Sophia Draf; Allen Frederic Ryan; Karl-Ludwig Bruchhage
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

Review 4.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

5.  Association of CARD8 Activating Polymorphism With Bone Erosion in Cholesteatoma Patients.

Authors:  Neel Sangal; John Yan; Jessica Pryor; Marcus L Elias; Biju Joseph; Luis Ulloa; Robert W Jyung
Journal:  Laryngoscope       Date:  2020-05-12       Impact factor: 2.970

6.  TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.

Authors:  Huaili Jiang; Yu Si; Zhuohao Li; Xi Huang; Suijun Chen; Yiqing Zheng; Guo Xu; Ximing Chen; Yubin Chen; Yi Liu; Hao Xiong; Qiuhong Huang; Maojin Liang; Zhigang Zhang
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

7.  Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS.

Authors:  Matthias Schürmann; Johannes F W Greiner; Verena Volland-Thurn; Felix Oppel; Christian Kaltschmidt; Holger Sudhoff; Barbara Kaltschmidt
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.